1-7 of 7
Janet Dunn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Quality of Life Data from a Prospective Randomised Trial of Newly Diagnosed Myeloma Patients with Renal Failure: Optimal Trial

Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD, Gulnaz Iqbal, PhD, Mark T Drayson, MB ChB, PhD FRCPath, Richard Brouwer, BSc, Sherin Varghese, MSc, BA, Stephen Schey, MBBS, Jindriska Lindsay, FRCPath, Janet Dunn, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
https://doi.org/10.1182/blood-2020-140937
Published: 2020
Journal Articles

Optimal - a Study of Bortezomib, Bendamustine and Dexamethasone (BBD) Vs Thalidomide, Bendamustine and Dexamethasone (BTD) in Patients with Renal Failure Defined As an Egfr below 30 Mls/Min

Karthik Ramasamy, MBBS MRCP FRCPath PhD, Mark T Drayson, MB ChB, PhD FRCPath, Gulnaz Iqbal, PhD, Victoria Stalker, BSc, MA, Salma Akhtar, BSc, MSc, Janet Dunn, PhD, Stephen Schey, MBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3135.
https://doi.org/10.1182/blood-2019-128157
Published: 2019
Journal Articles

Anticoagulation Therapy in Selected Cancer Patients at Risk of Recurrence of Venous Thromboembolism: Results of the Select-D™ Pilot Trial

Annie Young, PhD, Andrea Marshall, PhD, Jennifer Thirlwall, BSc, Catherine Hill, BSc, Danielle Hale, MA, Janet Dunn, PhD, Anand Lokare, MD FRCPath, MRCP, Ajay K. Kakkar, MBBS, Mark N. Levine, MD MSC, Oliver Chapman, MBBS, FRCPath, MRCP
Journal: Blood
Blood (2017) 130 (Supplement 1): 625.
https://doi.org/10.1182/blood.V130.Suppl_1.625.625
Published: 2017
Journal Articles

Diagnostic Pathways of Myeloma Patients Presenting to Hospital Care and Relationship to End Organ Damage: An Analysis from the Teamm (Tackling EArly Morbidity and Mortality in Myeloma) Trial in 977 Patients

Stella Bowcock, MDMA, Catherine Atkin, MD, Gulnaz Iqbal, PhD, Tim Planche, MDPhD, Guy Pratt, MD FRCP, FRCPath, Kwee Yong, PhD, Jill Wood, MPH, Kerry Raynes, MSc, Eric Low, BSc, Helen Higgins, MSc, Janet Dunn, PhD, Mark T Drayson, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2132.
https://doi.org/10.1182/blood.V130.Suppl_1.2132.2132
Published: 2017
Journal Articles

Tackling Early Morbidity and Mortality in Myeloma (TEAMM): Assessing the Benefit of Antibiotic Prophylaxis and Its Effect on Healthcare Associated Infections in 977 Patients

Mark T Drayson, MD PhD, Stella Bowcock, MDMA, Tim Planche, MDPhD, Gulnaz Iqbal, PhD, Jill Wood, MPH, Kerry Raynes, MSc, Guy Pratt, MD FRCP, FRCPath, Kwee Yong, PhD, Peter Hawkey, FRCPath, Helen Higgins, MSc, Janet Dunn, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 903.
https://doi.org/10.1182/blood.V130.Suppl_1.903.903
Published: 2017
Journal Articles

Assessment of Anti-Bacterial Antibodies in Multiple Myeloma Patients at Disease Presentation and in Response to Therapy: Implication for Patient Management

Ilaria Chicca, PhD, Jennifer LJ Heaney, PhD, Gulnaz Iqbal, PhD, Stella Bowcock, MDMA, Tim Planche, MDPhD, Jill Wood, MPH, Kerry Raynes, MSc, Peter Hawkey, FRCPath, Guy Pratt, MD FRCP, FRCPath, Kwee Yong, PhD, Helen Higgins, MSc, Janet Dunn, PhD, Mark T Drayson, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3036.
https://doi.org/10.1182/blood.V130.Suppl_1.3036.3036
Published: 2017
Journal Articles

Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials

Clinical Trials & Observations
Mark Drayson, Gulnaz Begum, Supratik Basu, Sudhaker Makkuni, Janet Dunn, Nicola Barth, J. Anthony Child
Journal: Blood
Blood (2006) 108 (6): 2013–2019.
https://doi.org/10.1182/blood-2006-03-008953
Published: 2006